Skip to main content
Premium Trial:

Request an Annual Quote

Genome Institute of Singapore Buys Three SOLiD Systems

NEW YORK (GenomeWeb News) – Applied Biosystems said today that the Genome Institute of Singapore has acquired three SOLiD DNA sequencing systems for use in studying the genetic underpinnings of cancer and other diseases.
 
GIS already had one SOLiD system on site, according to ABI. Researchers at the institute are studying how structural variants, such as copy number variations, single-base duplications, inversions, translocations, insertions, and deletions, contribute to the development of cancer.
 
"We evaluated several technologies for this kind of research, and concluded that the SOLiD System fits very well with our paired end di-tag technology and will provide us with a platform that enables rapid, accurate and cost-effective study of a variety of types of genetic variants present in cancer genomes," Yijun Ruan, associate director for genomic technologies at GIS, said in a statement.
 
Financial terms of the purchase were not disclosed.

The Scan

J&J Booster Support

A US Food and Drug Administration advisory panel has voted to support a booster dose of Johnson & Johnson's SARS-CoV-2 vaccine, according to the Los Angeles Times.

To Keep the Cases Moving

The president of the UK Royal College of Pathologists tells the Financial Times that more investment is needed to tackle a backlog of cases.

NAS Expels Archaeologist

Science reports Luis Jaime Castillo Butters' expulsion is the first of an international member from the US National Academy of Sciences.

PLOS Papers on Angelman Syndrome-Like Cases, Salmonella Paratyphi A, SARS-CoV-2 in Brazil

In PLOS this week: exome sequencing analysis of Angelman syndrome-like cases, genetic epidemiology of Salmonella Paratyphi A, and more.